...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Valpha14-Jalpha18 TCRalpha gene.
【24h】

Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Valpha14-Jalpha18 TCRalpha gene.

机译:从具有重排不变的Valpha14-Jalpha18 TCRalpha基因的胚胎干细胞在体外生成功能性NKT细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Establishment of a system with efficient generation of natural killer T (NKT) cells from embryonic stem (ES) cells would enable us to identify the cells with NKT-cell potential and obtain NKT cells with desired function. Here, using cloned ES (NKT-ES) cells generated by the transfer of nuclei from mature NKT cells, we have established a culture system that preferentially developed functional NKT cells and also identified early NKT progenitors, which first appeared on day 11 as a c-kit(+) population in the cocultures on OP9 cells with expression of Notch ligand, delta-like1 (OP9/Dll-1) and became c-kit(lo/-) on day 14. Interestingly, in the presence of Notch signals, NKT-ES cells differentiated only to thymic CD44(lo) CD24(hi) NKT cells producing mainly interleukin-4 (IL-4), whereas NKT cells resembling CD44(hi) CD24(lo) liver NKT cells producing mainly interferon gamma (IFN-gamma) and exhibiting strong adjuvant activity in vivo were developed in the switch culture starting at day 14 in the absence of Notch. The cloned ES culture system offers a new opportunity for the elucidation of the molecular events on NKT-cell development and for the establishment of NKT-cell therapy.
机译:建立能够从胚胎干(ES)细胞高效生成天然杀伤性T(NKT)细胞的系统将使我们能够鉴定具有NKT细胞潜能的细胞,并获得具有所需功能的NKT细胞。在这里,我们使用从成熟NKT细胞中转移核而产生的克隆ES(NKT-ES)细胞,建立了优先培养功能性NKT细胞并鉴定出早期NKT祖细胞的培养系统,该细胞最初在第11天以c出现。在带有Notch配体delta-like1(OP9 / Dll-1)表达的OP9细胞上共培养的-kit(+)群体在第14天成为c-kit(lo /-)。有趣的是,在存在Notch信号的情况下,NKT-ES细胞仅分化为胸腺CD44(lo)CD24(hi)NKT细胞,主要产生白介素4(IL-4),而NKT细胞类似于CD44(hi)CD24(lo)肝NKT细胞,主要产生干扰素γ(从第14天开始,在没有Notch的情况下,在转换培养物中产生了IFN-γ)并在体内表现出强大的佐剂活性。克隆的ES培养系统为阐明有关NKT细胞发育的分子事件和建立NKT细胞疗法提供了新的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号